Cresco Labs Inc. (CRLBF) Other Non-Current Liabilities (2019 - 2026)

Cresco Labs (CRLBF) has reported Other Non-Current Liabilities for 8 consecutive years, with $194.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Non-Current Liabilities rose 29.36% year-over-year to $194.7 million; the trailing twelve-month figure through Jun 2026 stood at $194.7 million (up 29.36% YoY), and the FY2025 full-year result was $171.5 million, up 40.02% from the prior year.
• Other Non-Current Liabilities advanced to $194.7 million in Q2 2026 per CRLBF's latest filing, from $184.9 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $194.7 million in Q2 2026 and bottomed at $7.0 million in Q3 2022.
• Historically, Other Non-Current Liabilities has averaged $85.7 million across 5 years, with a median of $72.9 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Non-Current Liabilities retreated 18.14% in 2022, then surged 625.31% in 2024.
• Over 5 years, Other Non-Current Liabilities stood at $12.9 million in 2022, then jumped by 56.67% to $20.2 million in 2023, then soared by 505.92% to $122.5 million in 2024, then soared by 40.02% to $171.5 million in 2025, then climbed by 13.56% to $194.7 million in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $194.7 million, $184.9 million, and $171.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.